Abstracts tagged "Miscellaneous"

Abstract Number: 1177 • 2017 ACR/ARHP Annual Meeting
Airway Findings in Patients with Relapsing Polychondritis
Marcela A. Ferrada¹, James D. Katz², Keith A. Sikora³, Allen Clint⁴, Jeff Kim⁴, Wendy Goodspeed⁴, Robert Colbert⁵, Marcus Chen⁶, Arlene Sirajuddin⁴ and Peter C. Grayson², ¹NIAMS, National Institues of Health, Bethesda, MD, ²National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD, ³Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ⁴National Institutes of Health, Bethesda, MD, ⁵NIAMS/NIH, Bethesda, MD, ⁶NHLBI, National Institutes of Health, Bethesda, MD
Background/Purpose: Relapsing polychondritis (RP) is a rare multiorgan disease. Involvement of the upper and lower airways is associated with significant morbidity and mortality. Isolated airway…
Abstract Number: 2100 • 2017 ACR/ARHP Annual Meeting
An International Consensus Exercise to Develop Candidate Items for Classification Criteria in Relapsing Polychondritis
Marcela A. Ferrada¹, Peter A. Merkel², Keith A. Sikora³, Robert Colbert⁴, Chikashi Terao⁵, Hajime Yoshifuji⁶, Toshiki Nakajima⁷, Aman Sharma⁸, Shirish Sangle⁹, Dax Rumsey¹⁰, Christian Pagnoux¹¹, Larry Young¹², Colleen K. Correll¹³, Fabien Maldonado¹⁴, Robert Lebovics¹⁵, Alexander Gelbard¹⁴, Philip Zapata¹⁶, Allen Clint¹⁷, Otis Rickman¹⁴, Nitin Seam¹⁷, Guillaume Moulis¹⁸, Nathalie Costedoat-Chalumeau¹⁹, Clement J. Michet Jr.²⁰, James D. Katz²¹ and Peter C. Grayson²¹, ¹NIAMS, National Institues of Health, Bethesda, MD, ²Division of Rheumatology, University of Pennsylvania, Philadelphia, MN, ³Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ⁴National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ⁵Departments of Genetics and Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁶Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, ⁷Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan, ⁸Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, ⁹Louise Coote Lupus Unit, Rheumatology and Lupus, Guy's and St Thomas' Hospitals NHS Foundation Trust, London, United Kingdom, ¹⁰Stollery Children's Hospital, Edmonton, AB, Canada, ¹¹Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ¹²Medicine, University of Miami Miller School of Medicine, Miami, FL, ¹³University of Minnesota, Minneapolis, MN, ¹⁴Vanderbilt University Medical Center, Nashville, TN, ¹⁵Mt. Sinai St. Luke's Hospitals, New York, NY, ¹⁶The George Washington University School of Medicine and Health Sciences, Washington, DC, ¹⁷National Institutes of Health, Bethesda, MD, ¹⁸CIC 1436, Toiulouse, France, ¹⁹Service de médecine interne Pôle médecine, Hôpital Cochin, Centre de référence maladies auto-immunes et systémiques rares de l’île de France, Paris, France, ²⁰Division of Rheumatology, Mayo Clinic, Rochester, MN, ²¹National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD
Background/Purpose: There are no validated classification criteria for relapsing polychondritis (RP). Given that some manifestations of RP are organ- or life-threatening, it is imperative that…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].